News From Europe!
SEE OTHER BRANDS

Your daily news update on Europe

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on News From Europe!.

Greece Launches First-of-Its-Kind Nationwide Program to Reward Remote Workers

Greece Launches First-of-Its-Kind Nationwide Program to Reward Remote Workers

Travelers now receive a free 1-year Global Nomad Pass (USD $79.99 value), unlocking exclusive local discounts in 5 Greek cities, courtesy of WORKFROMGREECE.GR ATHENS, GREECE, June 17, 2025 /⁨EINPresswire.com⁩/ -- In a bold move to establish Greece...

People Rally in Brussels Over Gaza

People Rally in Brussels Over Gaza

(MENAFN) Over 75,000 individuals filled the streets of Brussels on Sunday, all wearing red to represent a "red line" drawn in opposition to what they described as Israel’s genocidal conduct in Gaza. The symbolic act aimed to convey the gravity of...

MY.music launches National Music Validator program for .MUSIC Artist Verification

MY.music launches National Music Validator program for .MUSIC Artist Verification

.MUSIC partners with local industry leaders to authenticate domain name registrations worldwide WILMINGTON, DE, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- MY.music, the official technology partner of the .MUSIC top-level domain (TLD),...

New EU Energy Directive Prompts Urgent Action for Real Estate Investors

New EU Energy Directive Prompts Urgent Action for Real Estate Investors

Dunaj Family Office Consulting highlights key steps ahead of EPBD implementation in 2026 VIENNA, AUSTRIA, June 16, 2025 /⁨EINPresswire.com⁩/ -- With the European Union’s updated Energy Performance of Buildings Directive (EPBD) set to come into...

EU Defends Schengen as Border Controls Mount Across Bloc

EU Defends Schengen as Border Controls Mount Across Bloc

(MENAFN) As the European Union commemorates 40 years since the signing of the Schengen Agreement, concerns are mounting over the renewed use of internal border checks within the Schengen Area — sparking debate over the future of border-free travel...

Cultivating young entrepreneurs: portugal aligns school curriculum with EU competency goals

Cultivating young entrepreneurs: portugal aligns school curriculum with EU competency goals

FAYETTEVILLE, GA, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- In an era defined by uncertainty and rapid change, equipping students with entrepreneurial skills has become more urgent than ever. A recent critical analysis sheds light on...

Defense of Europe as a Responsible Investment

Defense of Europe as a Responsible Investment

The last time the Western investment world saw a robust debate over the parameters of buying shares in the arms industry was roughly in the era of the Vietnam War. In the wake of that fraught conflict, thought-leading socially-responsible investor...

SaverOne Signs Preliminary Agreement with Leading European  ADAS Technology Provider for Sensor Fusion Collaboration

SaverOne Signs Preliminary Agreement with Leading European ADAS Technology Provider for Sensor Fusion Collaboration

This Collaboration Integrates SaverOne’s VRU Detection Solution into an ADAS Platform for Enhanced Road Safety Petah Tikvah, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company engaged in...

KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Patients Receiving Long-Term Prophylaxis

KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Patients Receiving Long-Term Prophylaxis

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of new data at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, United Kingdom that underscores the critical role of effective...

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"

OMER, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the receipt of an initial order for...

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)

Poster #1654 highlights clinically meaningful and durable increases in circulating neutrophils observed with mavorixafor treatment +/- G-CSF over 6-month study Poster #1669 highlights findings that investigators were willing and able to reduce...

Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Across More European Countries

Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Across More European Countries

FREMONT, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of its most...

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia: FDA PDUFA goal date of August 15, 2025 TNX-102 SL demonstrated statistically significant improvement in the...

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL for UK approval via MHRA’s International Recognition Procedure AVEROA actively seeking strategic...

EU Reach Forty Years of Schengen Agreement

EU Reach Forty Years of Schengen Agreement

(MENAFN) As the European Union commemorates four decades since the inception of the Schengen Agreement, it is encountering rising criticism regarding the increasing reinstatement of internal frontiers among Schengen nations — sparking debates...

Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia

Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorder BRAVE study will explore the potential of omaveloxolone to address the...

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up,...

IAEA director condemns attacks on Zaporozhye power plant

IAEA director condemns attacks on Zaporozhye power plant

(MENAFN) Rafael Grossi, Director General of the International Atomic Energy Agency (IAEA), has strongly condemned attacks on the Zaporozhye nuclear power plant (ZNPP), Europe’s largest nuclear facility. His statement came shortly after Russian...

Taskrabbit Reimagines the Retail Customer Experience, Launching New Integrated Solutions for Partners

Taskrabbit Reimagines the Retail Customer Experience, Launching New Integrated Solutions for Partners

Taskrabbit, the platform connecting people to skilled, reliable Taskers from their local communities, today announced the launch of Taskrabbit Partner Pages: custom landing pages that enable retailers to offer Taskrabbit services as a value-add...

Europe $750+ Mn Spinal Navigation Market Analysis and Forecasts 2023-2024 & 2025-2032 - Innovation Drives Surge, Overcoming Cost Barriers / AI and Augmented Reality Revolutionize Real-Time Guidance - ResearchAndMarkets.com

Europe $750+ Mn Spinal Navigation Market Analysis and Forecasts 2023-2024 & 2025-2032 - Innovation Drives Surge, Overcoming Cost Barriers / AI and Augmented Reality Revolutionize Real-Time Guidance - ResearchAndMarkets.com

The "Europe Spinal Navigation Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering. The Europe spinal navigation market was valued at $192.1 million in 2023 and is expected to reach $754.7 million by...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service